Accretion PharmaceuticalsNSE:ACCPL -3.14%30 Days Inventory is 141.61 as of Mar. 2026, which is 2% below its 10-year median of 144.01. GuruFocus rates NSE:ACCPL with a GF Score™ of 30/100. The stock has 6 warning signs investors should review. Among 919 Drug Manufacturers companies, Accretion Pharmaceuticals ranks better than 59.19% on this metric.
The historical rank and industry rank for Accretion Pharmaceuticals's Days Inventory or its related term are showing as below:
NSE:ACCPL'
s Days Inventory Range Over the Past 10 Years
Min: 114.84 Med: 144.01 Max: 187.82
Current: 143.44
During the past 5 years, Accretion Pharmaceuticals's highest Days Inventory was 187.82. The lowest was 114.84. And the median was 144.01.
NSE:ACCPL's Days Inventory is ranked better than 59.19% of 919
companies
in the Drug Manufacturers industry
Industry Median: 164.48
vs NSE:ACCPL: 143.44
Inventory Turnover measures how fast the company turns over its inventory within a year.
Accretion Pharmaceuticals's Inventory Turnover for the
six
months ended in Mar. 2026 was 1.29.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Accretion Pharmaceuticals's Inventory-to-Revenue for the
six
months ended in Mar. 2026 was 0.56.
Accretion Pharmaceuticals (NSE:ACCPL) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Accretion Pharmaceuticals's Inventory Turnover for the
six
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Accretion Pharmaceuticals's Inventory to Revenue for the
six
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Accretion Pharmaceuticals Days Inventory Related Terms
Accretion Pharmaceuticals Days Inventory Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:ACCPL vs LLY, JNJ, ABBV: Days Inventory Comparison
For the Drug Manufacturers - General subindustry, Accretion Pharmaceuticals's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Accretion Pharmaceuticals Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Accretion Pharmaceuticals's Days Inventory distribution charts can be found below:
* The bar in red indicates where Accretion Pharmaceuticals's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Accretion Pharmaceuticals (NSE:ACCPL) has a Days Inventory of 141.61 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Accretion Pharmaceuticals and its competitors. This is near median its historical median of 144.01. Over the past decade, Accretion Pharmaceuticals' Days Inventory has ranged from 114.84 to 187.82. According to the industry distribution chart, Accretion Pharmaceuticals ranks #375 out of 919 companies in the Drug Manufacturers industry, placing it in the top 40.8%.
Is Accretion Pharmaceuticals' Days Inventory too high?
Accretion Pharmaceuticals' current Days Inventory of 141.61 is near median its 10-year median of 144.01. Over the past 10 years, this metric has ranged from a low of 114.84 to a high of 187.82. The Drug Manufacturers industry median Days Inventory is 164.48. Accretion Pharmaceuticals' value of 141.61 is 13.9% below this industry median. Based on the distribution chart, Accretion Pharmaceuticals ranks #375 out of 919 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Accretion Pharmaceuticals has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does Accretion Pharmaceuticals' Days Inventory compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Accretion Pharmaceuticals ranks #375 out of 919 companies for Days Inventory. This puts Accretion Pharmaceuticals in the upper half of its industry. The industry median Days Inventory is 164.48. Accretion Pharmaceuticals' value of 141.61 is 13.9% below this benchmark. Historically, Accretion Pharmaceuticals' own Days Inventory has ranged from 114.84 to 187.82 over the past decade. While the company's 10-year median is 144.01 vs. the industry median of 164.48, Accretion Pharmaceuticals has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.48, based on 919 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Accretion Pharmaceuticals's current Days Inventory of 141.61 is 13.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Accretion Pharmaceuticals and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Accretion Pharmaceuticals's current Days Inventory is 141.61, which is near median its own 10-year median of 144.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Accretion Pharmaceuticals stock overvalued right now?
Accretion Pharmaceuticals (NSE:ACCPL) has a current Days Inventory of 141.61. The current Days Inventory is 141.61, which is near median its 10-year median of 144.01 and 13.9% below the Drug Manufacturers industry median of 164.48. Accretion Pharmaceuticals' overall GF Score™ is 30/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Accretion Pharmaceuticals (NSE:ACCPL), the current Days Inventory is 141.61 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Accretion Pharmaceuticals Ltd is engaged in the manufacturing of Medicinal & Pharmaceutical Products. The company manufactures tablets, oral liquid, capsule, cream, ointment, mouthwash, dusting powder, gel, ear drops, lotion, shampoo, powder, syrup, among others.
30GF Score
Get the complete analysis for NSE:ACCPL
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:ACCPL has been successfully added to your 